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Background
The broadly neutralizing antibody 2G12 binds a cluster of
high mannose oligosaccharides on the glycan shield of
HIV. In particular, it recognises the Manα1,2Man linkages
of the D1 and D3 arms of the oligosaccharide. Immuno-
gens that resemble the 2G12 epitope are therefore a desir-
able component of a future HIV-1 vaccine. Vaccine
candidates displaying self-carbohydrates have thus far
been unsuccessful at eliciting 2G12-like antibodies.
Inspired by the observation that the non-self sugar D-fruc-
tose (which resembles D-mannose when displayed in its
pyranose form) had a higher affinity for 2G12 than D-
mannose, we proposed to chemically synthesise D1 arm
mimics displaying fructose-like non-self sugars at the ter-
minus to enhance antigenicity and immunogenicity.
Methods
Small alkyl groups were chemically introduced into the C-
3, C-5 and C-6 positions (supported by modeling) of the
terminal mannose of the D1 arm. IC50s were measured
using competitive ELISA. The structural basis of the
enhanced inhibition was determined using X-ray crystal-
lography. These 'non-self' sugars were conjugated to
Qbeta virus particles using click-chemistry.
Results
Non-self mimics of the D1 arm were successfully synthe-
sized. Introduction of non-self modifications were not
only tolerated in the 2G12 binding site but in one partic-
ular case, the C-6 methyl structure, showed higher affinity
for 2G12 than the natural substrate. A crystal structure of
this sugar in complex with Fab 2G12 dimer revealed addi-
tional hydrophobic interactions were responsible for the
enhanced antigenicity. Conjugation of these oligosaccha-
rides to Qbeta virus scaffold created high affinity glycan
shield mimics for use as immunogens.
Conclusion
A non-self D1 arm mimic has been synthesized and
shown to bind with higher affinity to 2G12 than its natu-
ral epitope. Conjugation of this oligosaccharide to Qbeta
was shown to be an effective mimic of the HIV-1 glycan
shield. We anticipate that these non-self oligosaccharides
are good candidates as synthetic carbohydrate anti-HIV
immunogens and are currently under investigation.
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